• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LFSPROShiny:一款用于预测和可视化携带有害种系突变家族癌症风险的交互式R/Shiny应用程序。

LFSPROShiny: an interactive R/Shiny app for prediction and visualization of cancer risks in families with deleterious germline mutations.

作者信息

Nguyen Nam H, Dodd-Eaton Elissa B, Peng Gang, Corredor Jessica L, Jiao Wenwei, Woodman-Ross Jacynda, Arun Banu K, Wang Wenyi

机构信息

Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Department of Statistics, Rice University, Houston, TX.

出版信息

medRxiv. 2023 Aug 15:2023.08.11.23293956. doi: 10.1101/2023.08.11.23293956.

DOI:10.1101/2023.08.11.23293956
PMID:37645796
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10462184/
Abstract

PURPOSE

LFSPRO is an R library that implements risk prediction models for Li-Fraumeni syndrome (LFS), a genetic disorder characterized by deleterious germline mutations in the gene. To facilitate the use of these models in clinics, we developed LFSPROShiny, an interactive R/Shiny interface of LFSPRO that allows genetic counselors (GCs) to perform risk predictions without any programming components, and further visualize the risk profiles of their patients to aid the decision-making process.

METHODS

LFSPROShiny implements two models that have been validated on multiple LFS patient cohorts: a competing-risk model that predicts cancer-specific risks for the first primary, and a recurrent-event model that predicts the risk of a second primary tumor. Starting with a visualization template, we keep regular contact with GCs, who ran LFSPROShiny in their counseling sessions, to collect feedback and discuss potential improvement. Upon receiving the family history as input, LFSPROShiny renders the family into a pedigree, and displays the risk estimates of the family members in a tabular format. The software offers interactive overlaid side-by-side bar charts for visualization of the patients' cancer risks relative to the general population.

RESULTS

We walk through a detailed example to illustrate how GCs can run LFSPROShiny in clinics, from data preparation to downstream analyses and interpretation of results with an emphasis on the utilities that LFSPROShiny provides to aid decision making.

CONCLUSION

Since Dec 2021, we have applied LFSPROShiny to over 100 families from counseling sessions at MD Anderson Cancer Center. Our study suggests that software tools with easy-to-use interfaces are crucial for the dissemination of risk prediction models in clinical settings, hence serving as a guideline for future development of similar models.

摘要

目的

LFSPRO是一个R语言库,用于实现李-弗劳梅尼综合征(LFS)的风险预测模型,LFS是一种遗传性疾病,其特征是该基因存在有害的种系突变。为便于在临床中使用这些模型,我们开发了LFSPROShiny,它是LFSPRO的交互式R/Shiny界面,使遗传咨询师(GC)无需任何编程组件即可进行风险预测,并进一步可视化其患者的风险概况,以辅助决策过程。

方法

LFSPROShiny实现了两个已在多个LFS患者队列中得到验证的模型:一个竞争风险模型,用于预测首次原发性癌症的特定癌症风险;一个复发事件模型,用于预测第二次原发性肿瘤的风险。从一个可视化模板开始,我们与在咨询会议中运行LFSPROShiny的GC保持定期联系,以收集反馈并讨论潜在的改进。在接收到家族史作为输入后,LFSPROShiny将家族呈现为一个谱系,并以表格形式显示家庭成员的风险估计值。该软件提供交互式并排叠加柱状图,以可视化患者相对于一般人群的癌症风险。

结果

我们通过一个详细的例子来说明GC如何在临床中运行LFSPROShiny,从数据准备到下游分析以及结果解释,重点强调LFSPROShiny为辅助决策提供的实用功能。

结论

自2021年12月以来,我们已将LFSPROShiny应用于MD安德森癌症中心咨询会议的100多个家庭。我们的研究表明,具有易于使用界面的软件工具对于在临床环境中传播风险预测模型至关重要,因此可为未来类似模型的开发提供指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c7/10462184/251ccbcb70e9/nihpp-2023.08.11.23293956v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c7/10462184/c35fa3960176/nihpp-2023.08.11.23293956v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c7/10462184/02d300507771/nihpp-2023.08.11.23293956v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c7/10462184/b3d7987d27c6/nihpp-2023.08.11.23293956v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c7/10462184/c2754b57ce52/nihpp-2023.08.11.23293956v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c7/10462184/251ccbcb70e9/nihpp-2023.08.11.23293956v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c7/10462184/c35fa3960176/nihpp-2023.08.11.23293956v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c7/10462184/02d300507771/nihpp-2023.08.11.23293956v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c7/10462184/b3d7987d27c6/nihpp-2023.08.11.23293956v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c7/10462184/c2754b57ce52/nihpp-2023.08.11.23293956v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e0c7/10462184/251ccbcb70e9/nihpp-2023.08.11.23293956v1-f0005.jpg

相似文献

1
LFSPROShiny: an interactive R/Shiny app for prediction and visualization of cancer risks in families with deleterious germline mutations.LFSPROShiny:一款用于预测和可视化携带有害种系突变家族癌症风险的交互式R/Shiny应用程序。
medRxiv. 2023 Aug 15:2023.08.11.23293956. doi: 10.1101/2023.08.11.23293956.
2
LFSPROShiny: An Interactive R/Shiny App for Prediction and Visualization of Cancer Risks in Families With Deleterious Germline Mutations.LFSPROShiny:一个用于预测和可视化具有有害种系突变的家族中癌症风险的交互式 R/Shiny 应用程序。
JCO Clin Cancer Inform. 2024 Feb;8:e2300167. doi: 10.1200/CCI.23.00167.
3
Validating Risk Prediction Models for Multiple Primaries and Competing Cancer Outcomes in Families With Li-Fraumeni Syndrome Using Clinically Ascertained Data.利用临床确定的数据验证 Li-Fraumeni 综合征家族中多种原发性和竞争癌症结局的风险预测模型。
J Clin Oncol. 2024 Jun 20;42(18):2186-2195. doi: 10.1200/JCO.23.01926. Epub 2024 Apr 3.
4
Validating risk prediction models for multiple primaries and competing cancer outcomes in families with Li-Fraumeni syndrome using clinically ascertained data at a single institute.利用单一机构的临床确诊数据验证李-佛美尼综合征家族中多种原发性癌症和竞争性癌症结局的风险预测模型。
medRxiv. 2023 Sep 2:2023.08.31.23294849. doi: 10.1101/2023.08.31.23294849.
5
Estimating Mutation Carrier Probability in Families with Li-Fraumeni Syndrome Using LFSPRO.使用LFSPRO估计李-佛美尼综合征家族中的突变携带者概率。
Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):837-844. doi: 10.1158/1055-9965.EPI-16-0695. Epub 2017 Jan 30.
6
Performance of LFSPRO germline carrier risk predictions compared to standard genetic counseling practice on prospectively collected probands.与标准遗传咨询实践相比,LFSPRO种系携带者风险预测在前瞻性收集的先证者中的表现。
medRxiv. 2024 Jul 10:2024.07.09.24310095. doi: 10.1101/2024.07.09.24310095.
7
Penetrance Estimates Over Time to First and Second Primary Cancer Diagnosis in Families with Li-Fraumeni Syndrome: A Single Institution Perspective.Li-Fraumeni 综合征家系中首次和二次原发癌诊断的穿透率估计:单机构视角。
Cancer Res. 2020 Jan 15;80(2):347-353. doi: 10.1158/0008-5472.CAN-19-0725. Epub 2019 Nov 12.
8
Penetrance of Different Cancer Types in Families with Li-Fraumeni Syndrome: A Validation Study Using Multicenter Cohorts.家族性李-佛美尼综合征中不同癌症类型的外显率:多中心队列的验证研究。
Cancer Res. 2020 Jan 15;80(2):354-360. doi: 10.1158/0008-5472.CAN-19-0728. Epub 2019 Nov 12.
9
The profile and contribution of rare germline copy number variants to cancer risk in Li-Fraumeni patients negative for TP53 mutations.TP53 突变阴性的李-弗劳梅尼综合征患者中,罕见种系拷贝数变异对癌症风险的影响及贡献
Orphanet J Rare Dis. 2014 Apr 28;9:63. doi: 10.1186/1750-1172-9-63.
10
TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.180 个疑似李-佛美尼综合征家族的 TP53 种系突变检测:不同家族表型中癌症的突变检出率和相对频率。
J Med Genet. 2010 Jun;47(6):421-8. doi: 10.1136/jmg.2009.073429.